Fairvalue-Calculator Fairvalue-Calculator
EN DE

Neo Cremar Co (311390) Fair Value & Analysis

Basic Materials · KR · Market cap 38.8B KRW

Price2,570 KRW
Fair Value4,549 KRW
Upside+77.0%
Quality80/100
Evidence: Medium Range 4,523 KRW – 5,043 KRW

Fair value as of: Jun 25, 2026

Analysis

Neo Cremar Co (311390) currently trades at 2,570 KRW, while our model-based Fair Value estimate is 4,549 KRW — implying the stock looks roughly 77.0% undervalued today. We read business quality at 80/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Neo Cremar Co., Ltd. manufactures and sells functional food ingredients and additives in South Korea and internationally. The company offers microbiome, functional carbohydrate, functional protein, solubilizable functional ingredients, organic, and other products. It also provides functional foods, plant-based meat and cultured meat, customized health functional food, and pharmaceuticals business. Neo Cremar Co., Ltd. was founded in 1999 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Neo Cremar Co (311390) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 4,549 KRW versus a price of 2,570 KRW — about +77% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 311390?
Our 21-model fair value for Neo Cremar Co is 4,549 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 2,570 KRW.
What is the quality score of 311390?
Neo Cremar Co has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.